{
    "clinical_study": {
        "@rank": "57061", 
        "acronym": "PRIMULTI", 
        "arm_group": [
            {
                "arm_group_label": "Culprit lesion revascularization", 
                "arm_group_type": "Active Comparator", 
                "description": "Only the culprit lesion is treated whereas other study lesions are left un-treated."
            }, 
            {
                "arm_group_label": "Full revascularization", 
                "arm_group_type": "Active Comparator", 
                "description": "Culprit lesion is treated initially and all other lesions with diameter stenosis angiographically >50% and FFR <0.80 are treated in a separate procedure within the index hospitalization. Stenoses > 90% are treated without prior FFR."
            }
        ], 
        "brief_summary": {
            "textblock": "In patients with ST-elevation myocardial infarction (STEMI) the primary treatment is acute\n      angioplasty of the acute occlusion (culprit lesion). In STEMI patients with multi vessel\n      disease (MVD) no evidence based treatment of the non-culprit lesions exists. We aim to\n      provide evidence as to whether full revascularization or revascularization of the culprit\n      lesion only provides the best prognosis for the patient."
        }, 
        "brief_title": "Primary PCI in Patients With ST-elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "ST-elevation Myocardial Infarction.", 
            "Multi Vessel Disease."
        ], 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Myocardial Infarction"
            ]
        }, 
        "detailed_description": {
            "textblock": "STEMI patients with MVD (30% of total STEMI population) are - following successful primary\n      angioplasty - randomized to either no additional percutaneous coronary intervention (PCI) of\n      other lesions or full revascularisation guided by fractional flow reserve (FFR).\n\n      Eligible coronary arteries must be >2.0 mm in diameter and at the discretion of the operator\n      suitable for PCI. Only arteries with angiographically stenoses > 50% can be randomized. All\n      randomized lesions with diameter stenosis > 50% and < 90% are evaluated by FFR and a FFR\n      value < 0.80 is considered significant and treated. Stenoses >90% are treated without prior\n      FFR.\n\n      Full revascularization is a priori obtained by means of PCI. If, however, PCI is considered\n      inferior to coronary artery bypass grafting the latter option can be chosen."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \u2265 18 years.\n\n          -  Acute onset of chest pain of < 12 hours' duration.\n\n          -  ST-segment elevation \u2265 0.1 millivolt in \u2265 2 contiguous leads, signs of a true\n             posterior infarction or documented newly developed left bundle branch block.\n\n          -  Culprit lesion in a major native vessel.\n\n          -  MVD (non-culprit vessels with angiographic stenosis >50%)\n\n          -  Successful primary PCI\n\n        Exclusion Criteria:\n\n          -  Pregnancy.\n\n          -  Known intolerance of acetylsalicylic acid, clopidogrel, heparin or contrast.\n\n          -  Inability to understand information or to provide informed consent.\n\n          -  Haemorrhagic diathesis or known coagulopathy.\n\n          -  Stent thrombosis\n\n          -  Significant left main stem stenosis\n\n          -  Cardiogenic shock at admittance"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "650", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01960933", 
            "org_study_id": "DANAMI-3-PRIMULTI"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Culprit lesion revascularization", 
                    "Full revascularization"
                ], 
                "intervention_name": "Percutaneous coronary intervention", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Full revascularization", 
                "intervention_name": "FFR", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "STEMI", 
            "MVD", 
            "Full revascularization", 
            "Culprit lesion revascularization only", 
            "Primary PCI"
        ], 
        "lastchanged_date": "October 14, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Hans Henrik T Hansen, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Aalborg", 
                        "country": "Denmark", 
                        "zip": "9100"
                    }, 
                    "name": "Aalborg University Hospital"
                }, 
                "investigator": {
                    "last_name": "Hans Henrik T Hansen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Hans E B\u00f8tker, MD, DMSci"
                }, 
                "facility": {
                    "address": {
                        "city": "Aarhus", 
                        "country": "Denmark", 
                        "zip": "8200"
                    }, 
                    "name": "Skejby University Hospital"
                }, 
                "investigator": {
                    "last_name": "Hans E B\u00f8tker, MD, DMSci", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "steffen.helqvist@regionh.dk", 
                    "last_name": "Steffen Helqvist, MD, DMSci", 
                    "phone": "+4535452017"
                }, 
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark", 
                        "zip": "2100"
                    }, 
                    "name": "Rigshospitalet, University of Copenhagen"
                }, 
                "investigator": [
                    {
                        "last_name": "Lene Holmvang, MD, DMSci", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Peter Clemmensen", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Erik J\u00f8rgensen, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Kari Saunam\u00e4ki, MD. DMSci", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Frants Pedersen, MD, DMSci", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Lisette Okkels, MD, DMSci"
                }, 
                "facility": {
                    "address": {
                        "city": "Odense", 
                        "country": "Denmark", 
                        "zip": "5000"
                    }, 
                    "name": "Odense University Hospital"
                }, 
                "investigator": {
                    "last_name": "Lisette Okkels, MD, DMSci", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Primary PCI in Patients With ST-elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization A Randomised Comparison of the Clinical Outcome After Complete Revascularisation Versus Treatment of the Infarct-related Artery Only During Primary Percutaneous Coronary Intervention", 
        "overall_contact": {
            "email": "steffen.helqvist@regionh.dk", 
            "last_name": "Steffen Helqvist, MD, DMSci", 
            "phone": "+4535452017"
        }, 
        "overall_contact_backup": {
            "email": "lars.koeber@regionh.dk", 
            "last_name": "Lars K\u00f8ber, MD, DMSci", 
            "phone": "+4535452017"
        }, 
        "overall_official": [
            {
                "affiliation": "Rigshospitalet, University of Copenhagen, Denmark", 
                "last_name": "Steffen Helqvist, MD, DMSci", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Rigshospitalet, University of Copenhagen, Denmark", 
                "last_name": "Thomas Engstr\u00f8m, MD, DMSci", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Rigshospitalet, University of Copenhagen, Denmark", 
                "last_name": "Henning Kelb\u00e6k, MD. DMSci", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Rigshospitalet, University of Copenhagen, Denmark", 
                "last_name": "Lars K\u00f8ber, MD, Prof., DMSci", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Health and Medicines Authority", 
                "Denmark: Ethics Committee"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Composite of all cause death, myocardial infarction, or ischemia (either subjective or objective)  driven revascularization of non-culprit coronary lesions eligible for and randomized to  either of the two treatment arms at the time of the index procedure", 
            "measure": "All cause death, myocardial infarction or revascularization", 
            "safety_issue": "No", 
            "time_frame": "48 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01960933"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Thomas Engstrom", 
            "investigator_title": "MD, Senior Consultant, DMSCi", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Cardiac death or myocardial infarction", 
                "safety_issue": "No", 
                "time_frame": "48 months"
            }, 
            {
                "measure": "Hospitalization for acute coronary syndrome or acute heart failure", 
                "safety_issue": "No", 
                "time_frame": "48 months"
            }, 
            {
                "measure": "Angina status and quality of life", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Infarct size in relation to area at risk as determined by MRI", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Cardiac death, myocardial infarction, repeat revascularisation or occurrence of definite stent thrombosis (according to ARC definition) of non culprit lesions", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }, 
            {
                "measure": "Wall motion index (WMI) determined by echocardiography", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Odense University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Aalborg Universityhospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Aarhus University Hospital", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Rigshospitalet, Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}